MASTERINVEST Kapitalanlage GmbH Acquires 726 Shares of McKesson Corporation $MCK

MASTERINVEST Kapitalanlage GmbH lifted its holdings in McKesson Corporation (NYSE:MCK) by 88.1% in the 1st quarter, according to its most recent filing with the SEC. The firm owned 1,550 shares of the company’s stock after purchasing an additional 726 shares during the period. MASTERINVEST Kapitalanlage GmbH’s holdings in McKesson were worth $1,341,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. University of Texas Texas AM Investment Management Co. purchased a new stake in McKesson during the fourth quarter worth $25,000. Swiss RE Ltd. purchased a new position in shares of McKesson in the 4th quarter valued at $26,000. State of Wyoming purchased a new position in shares of McKesson in the 2nd quarter valued at $29,000. Vermillion & White Wealth Management Group LLC bought a new position in shares of McKesson in the 3rd quarter worth $33,000. Finally, Board of the Pension Protection Fund bought a new position in shares of McKesson in the 4th quarter worth $33,000. 85.07% of the stock is currently owned by institutional investors.

Insider Activity at McKesson

In related news, EVP Thomas L. Rodgers sold 699 shares of McKesson stock in a transaction that occurred on Tuesday, June 2nd. The shares were sold at an average price of $735.27, for a total value of $513,953.73. Following the completion of the sale, the executive vice president directly owned 2,268 shares in the company, valued at $1,667,592.36. This trade represents a 23.56% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, EVP Michele Lau sold 3,550 shares of the business’s stock in a transaction that occurred on Tuesday, May 26th. The stock was sold at an average price of $761.09, for a total transaction of $2,701,869.50. Following the sale, the executive vice president directly owned 3,247 shares in the company, valued at approximately $2,471,259.23. This represents a 52.23% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold 28,748 shares of company stock valued at $22,262,035 over the last 90 days. Company insiders own 0.06% of the company’s stock.

McKesson Price Performance

Shares of MCK stock opened at $797.33 on Thursday. The stock’s fifty day moving average price is $767.45 and its 200 day moving average price is $838.22. McKesson Corporation has a 1-year low of $637.00 and a 1-year high of $999.00. The company has a market cap of $93.35 billion, a price-to-earnings ratio of 20.73, a price-to-earnings-growth ratio of 1.32 and a beta of 0.31.

McKesson (NYSE:MCK) last released its quarterly earnings results on Thursday, May 7th. The company reported $11.69 EPS for the quarter, beating analysts’ consensus estimates of $11.56 by $0.13. The company had revenue of $96.30 billion during the quarter, compared to analysts’ expectations of $101.35 billion. McKesson had a negative return on equity of 345.35% and a net margin of 1.18%.The firm’s revenue was up 6.0% compared to the same quarter last year. During the same period last year, the business posted $10.12 earnings per share. McKesson has set its FY 2027 guidance at 43.800-44.600 EPS. As a group, equities research analysts anticipate that McKesson Corporation will post 44.28 earnings per share for the current year.

McKesson Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Wednesday, July 1st. Investors of record on Monday, June 1st were given a $0.82 dividend. This represents a $3.28 annualized dividend and a dividend yield of 0.4%. The ex-dividend date of this dividend was Monday, June 1st. McKesson’s dividend payout ratio (DPR) is presently 8.53%.

Wall Street Analysts Forecast Growth

A number of equities research analysts recently weighed in on MCK shares. Barclays dropped their price objective on McKesson from $1,050.00 to $925.00 and set an “overweight” rating on the stock in a research report on Wednesday, June 10th. Citigroup reduced their target price on shares of McKesson from $975.00 to $945.00 and set a “buy” rating for the company in a report on Thursday, May 14th. UBS Group increased their price target on shares of McKesson from $1,000.00 to $1,050.00 and gave the company a “buy” rating in a research report on Friday, May 8th. Weiss Ratings cut shares of McKesson from a “buy (b)” rating to a “buy (b-)” rating in a report on Tuesday, July 7th. Finally, Bank of America cut their price objective on shares of McKesson from $1,040.00 to $1,000.00 and set a “buy” rating on the stock in a research report on Monday, April 6th. Fourteen research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company’s stock. Based on data from MarketBeat, McKesson has a consensus rating of “Moderate Buy” and a consensus target price of $960.53.

McKesson Company Profile

McKesson Corporation (NYSE: MCK) is a global healthcare services and distribution company that supplies pharmaceuticals, medical-surgical products and health care technology solutions. Founded in 1833 and headquartered in Irving, Texas, McKesson operates across the drug distribution and healthcare services value chain, connecting manufacturers, pharmacies, hospitals and health systems to help manage the movement of medicines and clinical supplies.

The company’s core activities include pharmaceutical wholesale distribution and logistics, specialty pharmacy services, and the provision of medical-surgical supplies to acute and non-acute care providers.